• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

6 Biotech Stocks I'm Looking to Buy as Hot Momentum Cools

My main focus right now is on stronger defense.
By JAMES "REV SHARK" DEPORRE
May 21, 2020 | 10:49 AM EDT
Stocks quotes in this article: AUPH, OCUL, KDMN, SDGR, BXRX, PSNL

Once again there isn't any major negative reaction to massive unemployment numbers. All the recent weekly reports have been taken in stride and have not caused any major selling.

The report Thursday morning wasn't as bad as expected but there are now 25 million continuing unemployment claims, which is going to have some repercussions even if the market doesn't seem to think so right now.

Although there is no selloff, the price action is lackluster this morning. Breadth is still quite good with 3,950 gainers to ,2950 decliners but the pockets of hot momentum have cooled and there doesn't seem to be the same sort of euphoria and froth we have experienced earlier this week.

The convention wisdom is that there is some inclination to take profits in front of a three-day weekend when there is a good run. That is likely to be the explanation if we have some softer action at this point.

My main focus right now is on stronger defense. After the recent run I want to keep accounts as close to highs as possible.

There are plenty of names that I'd like to buy but I will be trying to buy them on some dips rather than further strength at this time. A few good examples in the biotechnology sector are Aurinia Pharmaceuticals  (AUPH) , Ocular Therapeutix (OCUL) , Personalis, Inc. (PSNL) , Kadmon Holdings (KDMN) , Schrodinger, Inc. (SDGR) , and Baudax Bio (BXRX) .

From a trading standpoint, a pullback right now would be ideal but the market is seldom that accommodating.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long AUPH, OCUL, PSNL, KDMN, SDGR and BXRX.

TAGS: Investing | Markets | Small Cap | Stocks | Trading | Biotechnology

More from Stocks

I'm Warming Up to Carnival, but Not Ready to Climb Aboard Yet

Jonathan Heller
Jun 27, 2022 10:00 AM EDT

The stock price of a cruise line operator is becoming more reasonable, but its heavy debt load remains a huge concern.

AbbVie Rallies After Its Test of the Rising 200-Day Moving Average Line

Bruce Kamich
Jun 27, 2022 9:55 AM EDT

Let's review the charts and indicators.

A Hawkish Fed Will Make a V-Shaped Bounce Difficult to Sustain

James "Rev Shark" DePorre
Jun 27, 2022 8:15 AM EDT

Such bounces seemingly have been the norm for a while, but circumstances this time are quite different than any time since 2008-2009.

Let's Check Nike's Charts Ahead of Monday's Earnings

Bruce Kamich
Jun 27, 2022 8:12 AM EDT

Here's what traders who are still long NKE could continue to do.

Russia Defaults, G7, NATO, Market Catalyst, Earnings, Trading Wells Fargo

Stephen Guilfoyle
Jun 27, 2022 7:40 AM EDT

This is the first actual Russian default on foreign denominated debt since the Bolsheviks repudiated the Czar's debt-load in 1918.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login